Migraine Trials in Salt Lake City, United States
Conditions / Migraine / Salt Lake City, United States
Research into Migraine spans multiple therapeutic approaches and trial phases.
41 total trials for this combination
Showing top 10 of 41 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04571060 | Randomized Trial in Adult Participants With Acute Migraines | COMPLETED | PHASE3 |
| NCT03896009 | Maximizing Outcomes in Treating Acute Migraine | COMPLETED | PHASE3 |
| NCT02614196 | Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study | COMPLETED | PHASE3 |
| NCT00228605 | Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain | COMPLETED | PHASE3 |
| NCT04804033 | A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention | TERMINATED | PHASE2/PHASE3 |
| NCT03901482 | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine | COMPLETED | PHASE3 |
| NCT04458857 | A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age | COMPLETED | PHASE3 |
| NCT04464707 | A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age | COMPLETED | PHASE3 |
| NCT06616194 | A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine | RECRUITING | PHASE3 |
| NCT02456740 | Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention | COMPLETED | PHASE3 |